non-flash navigation

 

Clinical Review: 3000 Cases; Medical Uses of Cannabis in California 1993-2000

Abstract: The legalization of cannabis for medical use in California in 1996 has induced thousands of patients to seek physician approval for self-adopted treatment strategies. In the same period, legal pressure from the federal government has constrained many physicians from formally recommending cannabis for the treatment of conditions other than AIDS and cancer. The author's willingness to take patients at their word and to risk governmental scrutiny has made him the "doctor of last resort" for those seeking to use cannabis legally as a medication. The result is a unique set of data based on interviews with more than 3,000 patients.

Presented at:
The First National Clinical Conference On Cannabis Therapeutics, Iowa City, Iowa April 7, 2000




Total Patients:  3000
 
Analgesic Immunomodulator 1316
Antispasmodic/Anticonvulsant 680
Appetite Stimulant 31
Harm Reduction/Substitute 126
Psychotherapeutic 847

Harm Reduction:  126
 
Alcohol 104
Amphetamine 6
Cocaine 2
Opiate 9
Tobacco 3
Unspecified 2

Psychotherapeutic:  847
 
Antidepressant 369
Anxiolytic 478

Psychiatric Conditions:  781
 
Bipolar 71
Post Traumatic Stress Disorder 263
Depression 307
Anxiety 140

Age:
 
1 to 10 1
11 to 20 68
21 to 30 826
31 to 40 697
41 to 50 791
51 to 60 504
61 to 70 83
71 to 80 22
81 to 90 7
91 to 100 1

..................................Male:  2207 ..........Female:  793
 
Analgesic Immunomodulator 1006 310
Antispasmodic/Anticonvulsant 505 175
Appetite Stimulant 16 15
Harm Reduction/Substitute 110 16
Psychotherapeutic 570 277

Total:  3000
 
Seeking freedom from State prosecution 3000

 

(c)2000 Tod H. Mikuriya, M.D.

President,
California Cannabis Research Medical Group
510-548-1188 fax 843-5187 email [email protected]

 
 

The above is a summary of an oral presentation at:

The First National Clinical Conference

On Cannabis Therapeutics, Iowa City, Iowa

April 7, 2000